iSpecimen Announces 1-for-40 Reverse Split Reducing Outstanding Shares to 1.316M
iSpecimen will execute a 1-for-40 reverse stock split effective April 27, 2026, reducing its 52,639,796 outstanding shares to 1,316,032 shares. The split will adjust option, warrant and RSU terms proportionally and aims to boost the stock price to meet Nasdaq Capital Market bid requirements.
1. Reverse Stock Split Details
iSpecimen will combine every 40 issued and outstanding common shares into one share, effective at 4:30 p.m. ET on April 27, 2026, with post-split trading beginning April 28. The company’s share count will decrease from 52,639,796 to 1,316,032 and the new CUSIP will be 45032V306, while the Nasdaq symbol remains unchanged.
2. Adjustments to Equity Awards
All outstanding stock options, warrants and restricted stock units will be adjusted proportionally for the 1-for-40 ratio, and the number of shares reserved under incentive plans will be reduced accordingly. Any fractional share resulting from the split will be rounded up to the nearest whole share at the participant level.
3. Compliance and Strategic Rationale
The reverse split is designed to raise the per-share trading price to comply with Nasdaq Capital Market minimum bid price requirements and to better attract institutional and other investors, supporting iSpecimen’s ongoing capital market strategy.